Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2011 1
2012 4
2013 5
2014 2
2015 2
2016 2
2019 1
2020 3
2021 7
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Relevance of Spike/Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2.
Barbieri SS, Cattani F, Sandrini L, Grillo MM, Amendola A, Valente C, Talarico C, Iaconis D, Turacchio G, Lucariello M, Lione L, Salvatori E, Amadio P, Garoffolo G, Maffei M, Galli F, Beccari AR, Sberna G, Marra E, Zoppi M, Michaelides M, Roscilli G, Aurisicchio L, Bertini R, Allegretti M, Pesce M. Barbieri SS, et al. Among authors: marra e. Signal Transduct Target Ther. 2023 May 19;8(1):203. doi: 10.1038/s41392-023-01488-3. Signal Transduct Target Ther. 2023. PMID: 37208343 Free PMC article. No abstract available.
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.
Fattore L, Cafaro G, Di Martile M, Campani V, Sacconi A, Liguoro D, Marra E, Bruschini S, Stoppoloni D, Cirombella R, De Nicola F, Pallocca M, Ruggiero CF, Castaldo V, Catizone A, Del Bufalo D, Viglietto G, Vecchione A, Blandino G, Aurisicchio L, Fanciulli M, Ascierto PA, De Rosa G, Mancini R, Ciliberto G. Fattore L, et al. Among authors: marra e. Oncogene. 2023 Jan;42(4):293-307. doi: 10.1038/s41388-022-02547-9. Epub 2022 Nov 23. Oncogene. 2023. PMID: 36418472 Free PMC article.
The promise of anti-ErbB3 monoclonals as new cancer therapeutics.
Aurisicchio L, Marra E, Roscilli G, Mancini R, Ciliberto G. Aurisicchio L, et al. Among authors: marra e. Oncotarget. 2012 Aug;3(8):744-58. doi: 10.18632/oncotarget.550. Oncotarget. 2012. PMID: 22889873 Free PMC article. Review.
Are Genetic Vaccines the Right Weapon against COVID-19?
Conforti A, Marra E, Roscilli G, Palombo F, Ciliberto G, Aurisicchio L. Conforti A, et al. Among authors: marra e. Mol Ther. 2020 Jul 8;28(7):1555-1556. doi: 10.1016/j.ymthe.2020.06.007. Epub 2020 Jun 10. Mol Ther. 2020. PMID: 32553431 Free PMC article. No abstract available.
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.
Minenkova O, Santapaola D, Milazzo FM, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Gritti G, Borleri G, Rambaldi A, Dental C, Viollet C, Pagano B, Salvini L, Marra E, Luberto L, Rossi A, Riccio A, Merlo Pich E, Santoro MG, De Santis R. Minenkova O, et al. Among authors: marra e. Mol Ther. 2022 May 4;30(5):1979-1993. doi: 10.1016/j.ymthe.2022.02.013. Epub 2022 Feb 12. Mol Ther. 2022. PMID: 35167974 Free PMC article.
Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery.
Milazzo FM, Chaves-Sanjuan A, Minenkova O, Santapaola D, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Merlo Pich E, Albertoni C, Marra E, Luberto L, Viollet C, Spagnoli LG, Riccio A, Rossi A, Santoro MG, Ballabio F, Paissoni C, Camilloni C, Bolognesi M, De Santis R. Milazzo FM, et al. Among authors: marra e. Mol Ther. 2023 Feb 1;31(2):362-373. doi: 10.1016/j.ymthe.2022.09.010. Epub 2022 Sep 15. Mol Ther. 2023. PMID: 36114671 Free PMC article.
37 results